IL125597A0 - Variants of thymidine kinase related nucleic acids sequences and their use in genic therapy - Google Patents

Variants of thymidine kinase related nucleic acids sequences and their use in genic therapy

Info

Publication number
IL125597A0
IL125597A0 IL12559797A IL12559797A IL125597A0 IL 125597 A0 IL125597 A0 IL 125597A0 IL 12559797 A IL12559797 A IL 12559797A IL 12559797 A IL12559797 A IL 12559797A IL 125597 A0 IL125597 A0 IL 125597A0
Authority
IL
Israel
Prior art keywords
variants
nucleic acids
thymidine kinase
related nucleic
acids sequences
Prior art date
Application number
IL12559797A
Other languages
English (en)
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9601603A external-priority patent/FR2744731B1/fr
Priority claimed from FR9609709A external-priority patent/FR2751988B1/fr
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of IL125597A0 publication Critical patent/IL125597A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C12N9/1211—Thymidine kinase (2.7.1.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL12559797A 1996-02-09 1997-01-31 Variants of thymidine kinase related nucleic acids sequences and their use in genic therapy IL125597A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9601603A FR2744731B1 (fr) 1996-02-09 1996-02-09 Nouveaux variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique
FR9609709A FR2751988B1 (fr) 1996-08-01 1996-08-01 Nouveaux variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique
PCT/FR1997/000193 WO1997029196A1 (fr) 1996-02-09 1997-01-31 Variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique

Publications (1)

Publication Number Publication Date
IL125597A0 true IL125597A0 (en) 1999-03-12

Family

ID=26232518

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12559797A IL125597A0 (en) 1996-02-09 1997-01-31 Variants of thymidine kinase related nucleic acids sequences and their use in genic therapy

Country Status (12)

Country Link
US (2) US6207150B1 (xx)
EP (1) EP0879288A1 (xx)
JP (1) JP2000505288A (xx)
KR (1) KR19990082124A (xx)
AU (1) AU720936B2 (xx)
BR (1) BR9707483A (xx)
CZ (1) CZ294497B6 (xx)
HU (1) HUP9902571A3 (xx)
IL (1) IL125597A0 (xx)
NO (1) NO983449L (xx)
SK (1) SK107998A3 (xx)
WO (1) WO1997029196A1 (xx)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6451571B1 (en) 1994-05-02 2002-09-17 University Of Washington Thymidine kinase mutants
EP1914304A1 (en) * 1998-10-14 2008-04-23 Darwin Molecular Corporation Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
CA2306443A1 (en) * 1997-10-14 1999-04-22 Darwin Molecular Corporation Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
CN1301821A (zh) * 1999-12-27 2001-07-04 上海博德基因开发有限公司 一种新的多肽——胸腺嘧啶核苷酸激酶11和编码这种多肽的多核苷酸
GB0008966D0 (en) * 2000-04-13 2000-05-31 Imp College Innovations Ltd Vectors for gene therapy
EP1283874A2 (en) * 2000-05-12 2003-02-19 Wolfgang Knecht Novel deoxynucleoside kinase enzyme variants
FR2823219B1 (fr) * 2001-04-10 2003-07-04 Pasteur Institut Mutants de la desoxycytidine kinase possedant une activite enzymatique elargie
US20040053836A1 (en) * 2002-04-22 2004-03-18 Philipp Mayer-Kuckuk Method for modulating the production of a selected protein in vivo
US20070167353A1 (en) * 2003-10-24 2007-07-19 John Hilfinger Prodrug composition
US20050137141A1 (en) * 2003-10-24 2005-06-23 John Hilfinger Prodrug composition
GB0413702D0 (en) 2004-06-18 2004-07-21 Molmed Spa Thymidine kinase
KR101726390B1 (ko) 2008-08-15 2017-04-12 더 유에이비 리서치 파운데이션 뉴클레오시드 프로드럭의 효소 활성자로서의 퓨린 뉴클레오시드 인산화효소
US20110023144A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of genes involved in amyotrophyic lateral sclerosis disease
US20110016543A1 (en) * 2008-12-04 2011-01-20 Sigma-Aldrich Co. Genomic editing of genes involved in inflammation
US20110023156A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Feline genome editing with zinc finger nucleases
US20110023141A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of genes involved with parkinson's disease
US20110023150A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genome editing of genes associated with schizophrenia in animals
US20110016540A1 (en) * 2008-12-04 2011-01-20 Sigma-Aldrich Co. Genome editing of genes associated with trinucleotide repeat expansion disorders in animals
US20110016546A1 (en) * 2008-12-04 2011-01-20 Sigma-Aldrich Co. Porcine genome editing with zinc finger nucleases
US20110023143A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of neurodevelopmental genes in animals
US20110023140A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Rabbit genome editing with zinc finger nucleases
US20110023152A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genome editing of cognition related genes in animals
US20110023146A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of genes involved in secretase-associated disorders
US20110030072A1 (en) * 2008-12-04 2011-02-03 Sigma-Aldrich Co. Genome editing of immunodeficiency genes in animals
US20110023147A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of prion disorder-related genes in animals
US20110023158A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Bovine genome editing with zinc finger nucleases
US20110023145A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of genes involved in autism spectrum disorders
US20110023148A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genome editing of addiction-related genes in animals
US20110023153A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of genes involved in alzheimer's disease
US20110023149A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of genes involved in tumor suppression in animals
US20110023154A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Silkworm genome editing with zinc finger nucleases
US20110016539A1 (en) * 2008-12-04 2011-01-20 Sigma-Aldrich Co. Genome editing of neurotransmission-related genes in animals
US20110023139A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of genes involved in cardiovascular disease
US20110016541A1 (en) * 2008-12-04 2011-01-20 Sigma-Aldrich Co. Genome editing of sensory-related genes in animals
US20110023151A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genome editing of abc transporters
AU2020306544A1 (en) * 2019-06-27 2021-12-02 Bionoxx Inc. Oncolytic virus with improved safety and anticancer effects

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10503641A (ja) * 1994-05-02 1998-04-07 ユニバーシティ オブ ワシントン チミジンキナーゼ変異体

Also Published As

Publication number Publication date
US6207150B1 (en) 2001-03-27
NO983449D0 (no) 1998-07-27
HUP9902571A2 (hu) 1999-11-29
KR19990082124A (ko) 1999-11-15
EP0879288A1 (fr) 1998-11-25
JP2000505288A (ja) 2000-05-09
BR9707483A (pt) 1999-04-06
NO983449L (no) 1998-07-27
WO1997029196A1 (fr) 1997-08-14
AU1606897A (en) 1997-08-28
AU720936B2 (en) 2000-06-15
CZ294497B6 (cs) 2005-01-12
CZ247998A3 (cs) 1998-11-11
SK107998A3 (en) 1999-01-11
US20020102247A1 (en) 2002-08-01
HUP9902571A3 (en) 2002-01-28

Similar Documents

Publication Publication Date Title
IL125597A0 (en) Variants of thymidine kinase related nucleic acids sequences and their use in genic therapy
EP0948513A4 (en) RECOMBINATION PRODUCT FOR THE DELIVERY OF ANTISENSE NUCLEIC ACIDS AND METHODS OF USE
NZ289028A (en) Use of antisense nucleic acids in the treatment of skin disease
ZA9710339B (en) Xanthines and their therapeutic use
PL335226A1 (en) Gene sequencer and related methods
IL115584A0 (en) Viral vectors and their use in gene therapy
IL132281A0 (en) Modified tnf alpha molecules dna encoding such modified tnf alpha molecules and vaccines comprising such modified tnf alpha molecules and dna
IL115107A0 (en) Nucleotide sequences of acp thioesterase genes and their use
HUP9801216A3 (en) Dna molecules, preparation thereof and use thereof in gene therapy
EP0817798A4 (en) NUCLEOTIDE AND PROTEIN SEQUENCES OF LAT GENES AND METHODS USING THE SAME
EP0960114A4 (en) POLYMORPHISM AND NEW GENES IN THE HUMAN HEMOCHROMATOSIS GENE REGION
ZA965342B (en) Beta-xylosidase nucleotide sequence encoding it and use thereof
GB9422891D0 (en) Improvements in and relating to the amplification and identification of nucleotide sequences
AU3979395A (en) DNA sequences and their use
AU1598599A (en) Anti-angiogenic gene therapy vectors and their use in treating angiogenesis-related diseases
ZA983740B (en) Novel amidine derivatives and their use in therapy
IL117917A0 (en) H influenzae HxuB and HxuC genes proteins and methods of use
GB9421223D0 (en) Tissue imaging in gene therapy
EP1001966A4 (en) SENESCENCE GENE AND ITS USE IN THE TREATMENT OF CANCER AND OTHER DISEASES
GB9501978D0 (en) Nucleic acids, proteins and their use in therapy
GB9827704D0 (en) Human rad1 nucleic acid polypeptides assays therapeutic methods and means
IL129241A0 (en) Nucleotide and protein sequence of mammastatin and methods of use
GB9502480D0 (en) DNA and protein sequences
GB2330142B (en) Nucleotide sequences and protein sciences
ZA968847B (en) Use of hyaluronan in gene therapy